# Autologous Mesenchymal Stromal Cell Therapy in Heart Failure

> **NCT00644410** · PHASE1,PHASE2 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 59 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **BIOLOGICAL:** Mesenchymal stromal cell
- **BIOLOGICAL:** Saline

## Key facts

- **NCT ID:** NCT00644410
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2015-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00644410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00644410, "Autologous Mesenchymal Stromal Cell Therapy in Heart Failure". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT00644410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*